<DOC>
	<DOCNO>NCT00574223</DOCNO>
	<brief_summary>The purpose study test efficacy combination treatment AllQbG10 patient perennial allergic rhinoconjunctivitis due house dust mite allergy double-blind placebo-controlled setting</brief_summary>
	<brief_title>A Study Investigate Immunomodulatory Therapy Adult Patients With Perennial Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>Mild moderate perennial allergic rhinoconjunctivits due hypersensitization towards house dust mite allergen Clinically relevant allergy ( perennial seasonal ) could potentially interfere patient 's study treatment schedule assessment Use concomitant medication could affect patient 's study treatment response assessment result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>